Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuroSigma
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeuroSigma

NeuroSigma

Public

LA-based NeuroSigma, Inc. develops bioelectronic products for neurological and neuropsychiatric disorders.

HQ
Los Angeles, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in Los Angeles, NeuroSigma, Inc. is a life science company dedicated to developing bioelectronic products aimed at treating neurological and neuropsychiatric disorders. Their core mission is to provide innovative, non-invasive treatment options for conditions like epilepsy, depression, and pediatric ADHD. The company's flagship product, the Monarch eTNS® System, is the first FDA-cleared device for treating pediatric ADHD in children aged 7 to 12 who are not on prescription medications. This device is designed for home use under caregiver supervision.

NeuroSigma has garnered attention and support from notable investors and experts in the medical field. The company's key achievements include the FDA clearance of the Monarch eTNS System, marking a significant milestone in non-pharmacological treatment options for ADHD. The overall impact of NeuroSigma's innovations lies in offering new hope and improved quality of life for patients with challenging neurological and neuropsychiatric conditions.

NeuroSigma - Similar Companies

Neuronetics logo

Neuronetics

neurostar.com

NeuroPace logo

NeuroPace

neuropace.com

NeuroBionics logo

NeuroBionics

Neurotype logo

Neurotype

Epic Neuro logo

Epic Neuro

Neurolink logo

Neurolink

Neuroview Technology logo

Neuroview Technology

neuroviewtech.com

StimScience logo

StimScience

somneesleep.com

NeurAegis logo

NeurAegis

neuraegis.com

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

NeuroSpire logo

NeuroSpire

neurospire.com

Attune Neurosciences logo

Attune Neurosciences

attuneneuro.com

NeuroOne Medical Technologies logo

NeuroOne Medical Technologies

nmtc1.com

Neurodyne logo

Neurodyne

Neurosity logo

Neurosity

neurosity.co

NeuroSigma - Quick Facts

Who are NeuroSigma's competitors?

Companies similar to NeuroSigma include Neuronetics, NeuroPace, NeuroBionics and Neurotype.

When was NeuroSigma founded?

NeuroSigma was founded in 2008.

Where is NeuroSigma's headquarters located?

NeuroSigma's headquarters is located in Los Angeles, CA, US.

When was NeuroSigma's last funding round?

NeuroSigma's most recent funding round was for $5M (USD) in December 2021.

How much has NeuroSigma raised to-date?

As of Dec 8, 2021, NeuroSigma has raised a total of $18.4M (USD).

How many employees does NeuroSigma have?

NeuroSigma has 7 employees as of Feb 5, 2024.

NeuroSigma - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Bioelectronic Devices
Tags
  • Healthtech
  • Medical
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334517Irradiation Apparatus Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3845Electromedical And Electrotherapeutic Apparatus
ISIC
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research